| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 04/20/2011 | CN101228262B Novel bacterium belonging to the genus bifidobacterium and utilization of the same |
| 04/20/2011 | CN101209254B New use of polyhydroxy galloyl-beta-D-glucose derivatives |
| 04/20/2011 | CN101199534B Anti-tumor function of raw panoxadiol derivative |
| 04/20/2011 | CN101167824B Medicine for treating liver damage and its preparing process |
| 04/20/2011 | CN101152308B Traditional Chinese medicine composition for treating abdominal pain and lax, and method for preparing the same |
| 04/20/2011 | CN101129367B S-omeprazole solid dispersion and composition containing the dispersion |
| 04/20/2011 | CN101121014B Enteric coated traditional Chinese medicine preparation for intestine-stabling and anti-diarrhea |
| 04/20/2011 | CN101073657B 'Traditional Chinese-medicinal preparation for treating oral ulcers |
| 04/20/2011 | CN101073407B Edible refreshing pearl and its production |
| 04/20/2011 | CN101069692B Medicine preparation containing centella triterpenic genine and preparing method thereof |
| 04/20/2011 | CN101062937B 18alpha- liquorice acid derivatives and preparation thereof |
| 04/20/2011 | CN101045090B Medicine for treating colonitis |
| 04/20/2011 | CN101028385B Medicine for treating alvelysis |
| 04/20/2011 | CN100998786B Traditional Chinese medicine composition granule for treating gastrointestinal disease and its preparing method |
| 04/20/2011 | CN100998782B Traditional Chinese medicine oral liquid for treating gastrointestinal disease and its preparing method |
| 04/20/2011 | CN100998780B Traditional Chinese medicine dripping pills for relieving exterior syndrome, removing dampness regulating the stomach and its preparing method |
| 04/20/2011 | CN100998778B Traditional Chinese medicine tablets for relieving exterior syndrome, removing dampness regulating the stomach and its preparing method |
| 04/19/2011 | US7928255 Intermediates for the preparation of lipoxin A4 analogs |
| 04/19/2011 | US7928219 chemically modified nucleic acid molecule; cancer; carcinoma, neovascularization, diabetic retinopathy, neovascular glaucoma, myopic degeneration and other proliferative diseases, restenosis and polycystic kidney disease |
| 04/19/2011 | US7928218 Treatment of any disease that responds to modulation of gene expression, for example cancer, proliferative, inflammatory, metabolic, autoimmune, neurologic, ocular diseases; in vivo stability and bioavailability |
| 04/19/2011 | US7928146 Topical applying adrenergic blocking agent, nitric oxide synthase inhibitor, prostaglandin, dopamine, morphine and 5-hydroxytryptamine; topical applying |
| 04/19/2011 | US7928125 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 04/19/2011 | US7928124 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 04/19/2011 | US7928119 Use of EP4 receptor ligands in the treatment of IL-6 involved diseases |
| 04/19/2011 | US7928092 Formulations and methods of treating inflammatory bowel disease |
| 04/19/2011 | US7928078 Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy |
| 04/19/2011 | US7927821 Methods of screening for compounds which bind G protein-coupled receptors |
| 04/19/2011 | US7927622 Methods of transnasal transport/immunization with highly adaptable carriers |
| 04/19/2011 | CA2476012C Substituted pyridinones as modulators of p38 map kinase |
| 04/19/2011 | CA2447751C Dental restorative materials |
| 04/19/2011 | CA2385659C Novel antiarrhythmic peptides |
| 04/19/2011 | CA2384417C Novel dicarboxylic acid derivatives with pharmaceutical properties |
| 04/19/2011 | CA2378778C Il-16 antagonists |
| 04/19/2011 | CA2320962C Novel mixed amylin activity compounds |
| 04/14/2011 | WO2011043695A1 Pharmaceutical composition for the prophylaxis and treatment of infectious and non-infectious diarrhoea |
| 04/14/2011 | WO2011043654A1 Methods for diagnosing irritable bowel syndrome |
| 04/14/2011 | WO2011043564A2 Composition containing black ginseng extracts for preventing or treating liver cancer |
| 04/14/2011 | WO2011043469A1 Method for efficient proliferation of kupffer cells, and use thereof |
| 04/14/2011 | WO2011043453A1 Activator for peroxisome proliferator activated receptor |
| 04/14/2011 | WO2011043387A1 Pyrazoloxazole compound |
| 04/14/2011 | WO2011043381A1 Pyrazolothiazole compound |
| 04/14/2011 | WO2011043371A1 Oxazole compound |
| 04/14/2011 | WO2011043136A1 Immunosuppressing agent comprising mesenchymal stem cell derived from adipose tissue, and use thereof |
| 04/14/2011 | WO2011042501A2 The intestine and muscle recovery |
| 04/14/2011 | US20110086919 High eicosapentaenoic acid producing strains of yarrowia lipolytica |
| 04/14/2011 | US20110086898 Pyrazolooxazole compound |
| 04/14/2011 | US20110086893 Oxa- and thiadiazoles and their use as metalloproteinase inhibitors |
| 04/14/2011 | US20110086884 Barium salt of benzimidazole derivative |
| 04/14/2011 | US20110086882 Pyrazolothiazole compound |
| 04/14/2011 | US20110086864 N-hydroxyamide derivatives and use thereof |
| 04/14/2011 | US20110086857 N-((1r,2s,5r)-5-(tert-butylamino)-2-((s)-3-(7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes |
| 04/14/2011 | US20110086853 Therapeutic Compounds |
| 04/14/2011 | US20110086849 novel benzoxazine benzimidazole derivative, a pharmaceutical composition comprising the same, and ause thereof |
| 04/14/2011 | US20110086834 Alkynyl alcohols as kinase inhibitors |
| 04/14/2011 | US20110086821 Tetracycline Compounds for Treatment of Cryptosporidium Parvum Related Disorders |
| 04/14/2011 | US20110086795 Small peptide modulators of potassium channel trafficking |
| 04/14/2011 | US20110086103 Novel mandelate salt of fesoterodine |
| 04/14/2011 | US20110086101 Dispersinb, 5-Fluorouracil, Deoxyribonuclease I and Proteinase K-Based Antibiofilm Compositions and Uses Thereof |
| 04/14/2011 | US20110086093 Method for increasing lactose tolerance in mammals exhibiting lactose intolerance |
| 04/14/2011 | US20110086064 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
| 04/14/2011 | US20110086057 OX40R Binding Agents |
| 04/14/2011 | US20110086050 Glycoprotein compositions |
| 04/14/2011 | US20110086039 Methods of Treating Liver Fibrosis and Pre-Cirrhosis with Epidermal Growth Factor Receptor Inhibitors |
| 04/14/2011 | US20110086032 Anti-fgf19 antibodies and methods using same |
| 04/14/2011 | US20110085990 Oral care methods and systems |
| 04/14/2011 | DE102009049662A1 2,5-Disubstituierte 2H-Indazole als EP2-Rezeptor-Antagonisten 2,5-disubstituted 2H-indazoles as EP2-receptor antagonists |
| 04/14/2011 | CA2777214A1 Methods of treating diseases with proanthocyanidin oligomers such as crofelemer |
| 04/14/2011 | CA2776964A1 The intestine and muscle recovery |
| 04/14/2011 | CA2776420A1 Methods for diagnosing irritable bowel syndrome |
| 04/13/2011 | EP2309261A1 Methods for evaluating tissue morphogenesis and morphogenic activity |
| 04/13/2011 | EP2308989A2 Pectin hydrolysis products |
| 04/13/2011 | EP2308963A2 System for processing lipoaspirate cells |
| 04/13/2011 | EP2308880A1 Tetracyclic compound |
| 04/13/2011 | EP2308861A1 Macrocyclic compounds useful as pharmaceuticals |
| 04/13/2011 | EP2308855A1 2,4-Diaminopyrimidine derivatives |
| 04/13/2011 | EP2308846A2 Caspase inhibitors and uses thereof |
| 04/13/2011 | EP2308845A2 Caspase inhibitors and uses thereof |
| 04/13/2011 | EP2308844A2 Caspase inhibitors and uses thereof |
| 04/13/2011 | EP2308833A2 Cyclic protein tyrosine kinase inhibitors |
| 04/13/2011 | EP2308498A1 Administration of Bifidobacterium breve during infancy to prevent inflammation later in life |
| 04/13/2011 | EP2308492A1 Process for preparing lansoprazole |
| 04/13/2011 | EP2308476A1 Colonic purgative composition with soluble binding agent |
| 04/13/2011 | EP2307444A1 Analysis of lactobacillus acidophilus la-5 signal interference molecules |
| 04/13/2011 | EP2307422A1 Novel spirochromanone carboxylic acids |
| 04/13/2011 | EP2307010A1 Thiazole compounds, and compositions and methods using same |
| 04/13/2011 | EP2306961A1 Composition and method for enhancing flouride uptake using bioactive glass |
| 04/13/2011 | EP2306843A1 Nutritional composition for infants delivered via caesarean section |
| 04/13/2011 | EP2013198B1 Solid-state form of amg 706 and pharmaceutical compositions thereof |
| 04/13/2011 | EP1572127B1 Enzyme treatment of foodstuffs for celiac sprue |
| 04/13/2011 | EP1542978B1 Novel bio-active molecules |
| 04/13/2011 | EP1539763B1 Azaindole kinase inhibitors |
| 04/13/2011 | CN1957987B Medicine preparation for treating infectious diseases, preparation method, and quality detection method |
| 04/13/2011 | CN1946412B Preventive and/or remedy for inflammatory bowel diseases |
| 04/13/2011 | CN1943753B A Chinese traditional medicinal composition for treatment of hepatitis B and its preparation method |
| 04/13/2011 | CN1882547B 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 04/13/2011 | CN1780635B Preventives or remedies for hepatopathy |
| 04/13/2011 | CN1625400B 2,4-pyrimidinediamine compounds and their uses |
| 04/13/2011 | CN102015697A Amide derivative and pharmaceutical composition containing the same |
| 04/13/2011 | CN102015656A Phenylpropionic acid derivative and use thereof |
| 04/13/2011 | CN102015638A Long-chain fatty acid elongation enzyme inhibitor comprising arylsulfonyl derivative as active ingredient |